Circulation. Arrhythmia and electrophysiology
-
Circ Arrhythm Electrophysiol · Aug 2014
Comparative StudySafety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures.
This study aimed to evaluate the safety of continuous periprocedural rivaroxaban administration during left atrial radiofrequency ablation (RFA) in comparison with uninterrupted oral vitamin K antagonist administration. Data about the use of rivaroxaban in the setting of left atrial RFA procedures are lacking. ⋯ In patients undergoing left atrial RFA, continuous periprocedural rivaroxaban use seems to be as safe as uninterrupted periprocedural phenprocoumon administration.